Analysts are weighing in today on biotech issue
), along with retailers
The Gap Inc.
). Here's a quick roundup of today's bearish brokerage notes.
This article by
was originally published on
Schaeffer's Investment Research
- Deutsche Bank lowered its rating for Dendreon to "sell" from
"hold" ahead of today's session. Since reporting
less-than-stellar earnings on August 8, the shares have dropped
30.5% to their current perch at $3.19. Stepping back, the stock
now sits at a year-to-date loss of 37.8%. Meanwhile, calls remain
the options of choice in DNDN's options pits. The stock's
Schaeffer's put/call open interest ratio (SOIR) of 0.50 ranks
higher than just 22% of other such readings taken over the past
year. In other words, DNDN's short-term traders are more
call-heavy than usual right now, relative to the last 52 weeks.
Given that short interest represents a brow-raising 34% of
Dendreon Corporation's available float, however, it is possible
that some of this call activity is due to short sellers
hedging their bearish bets
- Ignoring Gap's
quarterly same-store sales increase
, Canaccord Genuity and Janney slashed their price targets for
the stock to $44 from $45, and to $51 from $52, respectively.
Though GPS sports a year-to-date gain of 35.3%, the stock has
taken a 9.8% dive since tagging a new 13-year high of $46.56 on
Aug. 2, and was last seen hovering at $42.01. As such, GPS'
International Securities Exchange (ISE), Chicago Board Options
), and NASDAQ OMX PHLX (PHLX) 10-day put/call volume ratio of
1.07 ranks in the 86th percentile of its annual range. This means
The Gap Inc. speculators have bought to open puts over calls at
an accelerated clip during the past two weeks.
- Following last night's disappointing earnings report,
Aeropostale saw its price target sliced at Janney, Brean Capital,
Susquehanna, BMO, Wedbush, and KeyBanc. Meanwhile, BofA-Merrill
Lynch downgraded its rating for the stock to "underperform" from
"neutral." On the charts, ARO has fallen 17.4% over the past
year. What's more, in the last three months, the stock has
tumbled 34%, and has underperformed the broader
INDEXSP:.INX) by 25 percentage points. With that being said, the
brokerage bunch maintains
a pessimistic outlook
toward ARO, which sports 11 "holds" and three "sell" or worse
ratings, compared to just four "strong buy" endorsements. On the
other hand, the stock's 12-month price target of $14.89
represents expected upside of 35.6% to its current price of
$10.98 -- leaving plenty of room for additional price-target
cuts, which could pressure Aeropostale Inc lower.
Below, find some more great content from Schaeffer's Investment
Daily Game Plan - Narrow Range Day
Trading 101: Contrarian Signal?
Bulls Circle as Alcatel Lucent SA (ADR) (
) Runs Higher
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.